P S Uster
Overview
Explore the profile of P S Uster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harrington K, Syrigos K, Uster P, Zetter A, Lewanski C, Gullick W, et al.
Br J Cancer
. 2004 Jun;
91(2):366-73.
PMID: 15199395
5-Iodo-2'-deoxyuridine (IUdR) is an effective radiosensitiser but its clinical development has been limited by toxicity. Prolonged intravenous infusions of IUdR are necessary for optimal tumour uptake but cause dose-limiting myelosuppression....
2.
Harrington K, Rowlinson-Busza G, Syrigos K, Uster P, Vile R, Peters A, et al.
Int J Radiat Oncol Biol Phys
. 2001 Jun;
50(3):809-20.
PMID: 11395251
Purpose: The effect of total-body irradiation (TBI) on the biodistribution and pharmacokinetics of (111)In-DTPA-labeled pegylated liposomes (IDLPL) was evaluated in tumor-bearing nude mice as part of an ongoing effort to...
3.
Harrington K, Rowlinson-Busza G, Uster P, Vile R, Peters A, Stewart J
Int J Radiat Oncol Biol Phys
. 2001 Mar;
49(4):1141-8.
PMID: 11240257
Purpose: These studies were performed with the intention of examining the effect of single-fraction doses of radiotherapy (RT) on the tumor deposition of radiolabeled pegylated liposomes in an animal xenograft...
4.
Harrington K, Mohammadtaghi S, Uster P, Glass D, Peters A, Vile R, et al.
Clin Cancer Res
. 2001 Mar;
7(2):243-54.
PMID: 11234875
The biodistribution and pharmacokinetics of (111)In-DTPA-labeled pegylated liposomes (IDLPL) were studied in 17 patients with locally advanced cancers. The patients received 65-107 MBq of IDLPL, and nuclear medicine whole body...
5.
Harrington K, Rowlinson-Busza G, Syrigos K, Vile R, Uster P, Peters A, et al.
Clin Cancer Res
. 2001 Jan;
6(12):4939-49.
PMID: 11156255
Concomitant chemotherapy and radiotherapy (CCRT) has recently been shown to improve treatment outcome in a range of solid tumors. Pegylated liposomes have the potential to target drugs directly to tumors...
6.
Harrington K, Rowlinson-Busza G, Syrigos K, Abra R, Uster P, Peters A, et al.
Br J Cancer
. 2000 Aug;
83(5):684-8.
PMID: 10944612
The relationship between tumour size and uptake of(111)In-DTPA-labelled pegylated liposomes has been examined in a human head and neck cancer xenograft model in nude mice. The mean tumour uptake of(111)In-labelled...
7.
Harrington K, Rowlinson-Busza G, Uster P, Stewart J
Cancer Chemother Pharmacol
. 2000 Jul;
46(1):10-8.
PMID: 10912572
Purpose: To evaluate the in vitro and in vivo activity of unencapsulated doxorubicin (DOX) and cisplatin (CDDP) and their pegylated liposome encapsulated counterparts (PLED and PLEC) in a subcutaneous model...
8.
Harrington K, Rowlinson-Busza G, Syrigos K, Uster P, Abra R, Stewart J
Br J Cancer
. 2000 Jul;
83(2):232-8.
PMID: 10901376
The biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in tumour-bearing nude mice was studied to examine possible applications of pegylated liposome-targeted anti-cancer therapies. Nude mice received an intravenous injection of...
9.
Harrington K, Rowlinson-Busza G, Syrigos K, Uster P, Vile R, Stewart J
Clin Cancer Res
. 2000 Jun;
6(6):2528-37.
PMID: 10873109
The potential value of intratumoral or s.c. injections of pegylated liposomes as locoregionally targeted therapy of tumors and their draining lymph nodes was assessed in nude mice as part of...
10.
Uster P, Allen T, Daniel B, Mendez C, NEWMAN M, Zhu G
FEBS Lett
. 1996 May;
386(2-3):243-6.
PMID: 8647291
Transfer of MPEG(1900)-DSPE from micellar phase to pre-formed liposomes imparts long in vivo circulation half-life to an otherwise rapidly cleared lipid composition. MPEG(1900)-DSPE transfers efficiently and quickly in a time...